Odyssey Therapeutics
ODTX
#6493
Rank
ยฃ0.65 B
Marketcap
ยฃ13.59
Share price
-0.14%
Change (1 day)
N/A
Change (1 year)

Revenue for Odyssey Therapeutics (ODTX)

Revenue in 2026 (TTM): ยฃ3.1 Million

According to Odyssey Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ2.95 Million. In 2025 the company made a revenue of ยฃ2.22 Million a decrease over the revenue in the year 2024 that were of ยฃ3.34 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Odyssey Therapeutics from 2022 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ3.1 M39.82%
2025 ยฃ2.22 M-33.45%
2024 ยฃ3.34 M331.24%
2023 ยฃ0.77 M
2022N/A